Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-9-24
pubmed:abstractText
Inactivation of Fanconi anemia/BRCA pathway in some cancers causes increased sensitivity to various drugs used for chemo-therapy. Several approaches have been suggested to artificially disrupt this pathway for better treatment. In our study, we have utilized RNA interference technique to knock-down the expression of FANCD2 and sensitize cancer cells undergoing treatment with DNA damaging agents. For this purpose, we transiently depleted FANCD2 by siRNA in a number of breast, bladder, or liver cancer cell lines and screened for mitomycin C or gamma-irradiation sensitivity changes. We could show that knocking-down FANCD2 gene expression increases sensitivity of cancer cells to mitomycin C and to less extent to gamma-rays. Importantly, this effect strongly correlates to repopulation ability of cancer cells and those cell lines with significant FANCD2 depletion revealed decreased recurrence capacity. In summary, the results we presented show proof of principle that opens new possibilities for further preclinical trials.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0304-3835
pubmed:author
pubmed:issnType
Print
pubmed:day
28
pubmed:volume
256
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
186-95
pubmed:meshHeading
pubmed-meshheading:17643815-Antibiotics, Antineoplastic, pubmed-meshheading:17643815-Breast Neoplasms, pubmed-meshheading:17643815-Cell Line, Tumor, pubmed-meshheading:17643815-Cell Proliferation, pubmed-meshheading:17643815-DNA Damage, pubmed-meshheading:17643815-Dose-Response Relationship, Drug, pubmed-meshheading:17643815-Dose-Response Relationship, Radiation, pubmed-meshheading:17643815-Fanconi Anemia Complementation Group D2 Protein, pubmed-meshheading:17643815-Female, pubmed-meshheading:17643815-Gamma Rays, pubmed-meshheading:17643815-Gene Expression Regulation, Neoplastic, pubmed-meshheading:17643815-Humans, pubmed-meshheading:17643815-Liver Neoplasms, pubmed-meshheading:17643815-Male, pubmed-meshheading:17643815-Mitomycin, pubmed-meshheading:17643815-RNA, Small Interfering, pubmed-meshheading:17643815-RNA Interference, pubmed-meshheading:17643815-Transfection, pubmed-meshheading:17643815-Urinary Bladder Neoplasms
pubmed:year
2007
pubmed:articleTitle
FANCD2 depletion sensitizes cancer cells repopulation ability in vitro.
pubmed:affiliation
Group of Mutagenesis, Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't